Marcel Doerflinger Lorne Infection and Immunity 2018

Abstracts this author is presenting:

• CRISPR/Cas9 screens identify novel host-pathogen interactions as potential drug targets for treatment of Burkholderia pseudomallei Melioidosis — SESSION 5: Host-pathogens II